Skip to main content

Our Journey
Our Technology
Pipeline

Leadership
Investors
Get in Touch

Event Details

Overview
Press Releases
Events
Presentations
Corporate Governance
Analyst Coverage
Stock Information
SEC Filings
Investor FAQs

Investor Contact

Jill Steier
Executive Director, Investor Relations & Corporate Communications
Jill.Steier@kalarx.com
781-996-5252

Hannah Deresiewicz
hannah.deresiewicz@sternir.com
212-362-1200

Fourth Quarter 2020 Financial Results

Feb 25, 2021 at 8:00 AM EST

Click here for webcast

Our Journey
Our Technology
Pipeline
Leadership
- Management Team
- Board of Directors
Investors
Get in Touch

©2021 Kala Pharmaceuticals All rights reserved. AMPPLIFY is a trademark and INVELTYS is a registered trademark of Kala Pharmaceuticals.
US-INV-1900184 January 2021

Terms of Use Privacy Statement Accessibility Policy